Sign in

Kemira Oyj KEMIRA.HE

Price 17.8 EUR
as of 2026-09-03
46/100
Weak
Quality40
Growth20
Balance-sheet strength55
Valuation65
Momentum34
Income75

Composite 46/100; the shares have moved about 24% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 20/100 — a strong mark against it.

Case for

Income ranks 75/100 — a strong point in its favour. Valuation ranks 65/100 — a moderate point in its favour. Balance-sheet strength ranks 55/100 — a slight point in its favour.

Case against

Growth ranks 20/100 — a strong mark against it. Momentum ranks 34/100 — a moderate mark against it. Quality ranks 40/100 — a slight mark against it.

What the company does Kemira Oyj supplies chemicals for water treatment, packaging & hygiene, and pulp production, leveraging digital technologies to improve efficiency and sustainability.

Key financials ROE 9.5%, ROA 5.0%, ROCE 9.7%; gross/operating/net margins 16.7%/8.1%/5.3%; revenue growth -0.1%, EPS growth -34.3%.

Stock health Sideravia overall score 48.2 (weak quality, attractively valued, weak momentum); Piotroski F-Score 5/9, Altman Z 2.58, debt/equity 0.50, interest coverage 9.07.

Price vs fair value The stock trades at a **discount** of 60.70% to our fair-value estimate and a **discount** of 11.34% to the analyst 12-month target. - Forward P/E 13.40 vs trailing 17.41 (Valuation 65.4) - PEG 0.45 signals undervaluation relative to growth (Sideravia) - Dividend yield 4.6% with payout 77.3% (Income 82.8) - Weak momentum scores (Momentum 31.9) despite strong income profile

Looking forward Analysts expect a forward P/E of 13.40 and EV/EBITDA of 6.72, implying recovery in margins and cash flows.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.